RecruitingNot ApplicableNCT06625983

Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care

Colorectal Cancer Screening Decision Support Tool in the Primary Care Bundle Questionnaire


Sponsor

Massachusetts General Hospital

Enrollment

80,000 participants

Start Date

Oct 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The research question we pose is, Does a colorectal cancer (CRC) screening decision support tool offered in advance of primary care visits increase CRC screening completion rates? Our work aims to answer this question by evaluating the effectiveness of an MGB decision support tool to 1) promote informed decisions about CRC screening for average risk patients ages 45-75, 2) deploy a decision support tool as part of a primary care bundle questionnaire, and 3) support patients in completing their preferred method of CRC screening.


Eligibility

Min Age: 45 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether a digital decision-support tool in primary care offices helps more adults get screened for colorectal (colon) cancer on time. You may be eligible if: you are between 45 and 75 years old; you are overdue for colon cancer screening; you are at average risk for colon cancer; and you have an upcoming annual visit scheduled at a participating clinic. You may NOT be eligible if: you are at high risk for colorectal cancer. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCRC decision tool

CRC decision tool included in the primary care bundle questionnaire


Locations(1)

Mass General Brigham

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06625983


Related Trials